【ALPHA 0303 交流专区】

icy97

IPO Prospectus

ALPHA IVF GROUP BERHAD

Subject

INITIAL PUBLIC OFFERING ("IPO") OF 1,458,000,000 ORDINARY SHARES IN ALPHA IVF GROUP BERHAD ("ALPHA IVF" OR "COMPANY") ("IPO SHARES") IN CONJUNCTION WITH THE LISTING OF AND QUOTATION FOR ITS ENTIRE ISSUED ORDINARY SHARES ON THE ACE MARKET OF BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") COMPRISING A PUBLIC ISSUE OF 364,500,000 NEW SHARES ("ISSUE SHARES") AND OFFER FOR SALE OF 1,093,500,000 EXISTING SHARES ("OFFER SHARES") INVOLVING: (I) AN INSTITUTIONAL OFFERING OF 1,239,300,000 IPO SHARES (COMPRISING 1,093,500,000 OFFER SHARES AND 145,800,000 ISSUE SHARES) TO INSTITUTIONAL AND SELECTED INVESTORS, INCLUDING BUMIPUTERA INVESTORS APPROVED BY THE MINISTRY OF INVESTMENT, TRADE AND INDUSTRY, MALAYSIA; AND (II) A RETAIL OFFERING OF 218,700,000 ISSUE SHARES TO THE DIRECTORS, ELIGIBLE EMPLOYEES AND ELIGIBLE PERSONS WHO HAVE CONTRIBUTED TO THE SUCCESS OF ALPHA IVF AND ITS SUBSIDIARIES ("GROUP"), AND THE MALAYSIAN PUBLIC AT AN IPO PRICE OF RM0.32 PER IPO SHARE, PAYABLE IN FULL UPON APPLICATION.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3427306

Attachments Alpha IVF - Prospectus (Part 1).pdf Alpha IVF - Prospectus (Part 2).pdf Alpha IVF - Prospectus (Part 3).pdf Alpha IVF - Detailed Procedures for Application and Acceptance.pdf

Opening of application	01 Mar 2024
Closing of application	08 Mar 2024
Balloting of application	12 Mar 2024
Allotment of IPO shares to successful applicants	20 Mar 2024
Tentative listing date	22 Mar 2024

icy97

ALPHA IVF GROUP BERHAD INITIAL PUBLIC OFFERING ("IPO") OF 1,458,000,000 ORDINARY SHARES ("SHARES") IN ALPHA IVF GROUP BERHAD ("ALPHA IVF" OR "COMPANY") IN CONJUNCTION WITH THE LISTING OF AND QUOTATION FOR ITS ENTIRE ISSUED ORDINARY SHARES ON THE ACE MARKET OF BURSA MALAYSIA SECURITIES BERHAD COMPRISING A PUBLIC ISSUE OF 364,500,000 NEW SHARES AND OFFER FOR SALE OF 1,093,500,000 EXISTING SHARES AT AN IPO PRICE OF RM0.32 PER ISSUE SHARE / OFFER SHARE, PAYABLE IN FULL UPON APPLICATION

Tricor Investor & Issuing House Services Sdn Bhd (“TIIH”) wishes to announce that the 194,400,000 Issue Shares made available for application by the Malaysian public have been oversubscribed.

A total of 6,894 applications for 530,070,600 Issue Shares with a value of RM169,622,592.00 were received from the Malaysian public, which represents an overall oversubscription rate of 1.73 times.

The notices of allotment will be posted to all successful applicants on 20 March 2024.


https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3430150

Attachments PRESS RELEASE-ALPHA IVF GROUP BERHAD BERHAD 1.pdf PRESS RELEASE-ALPHA IVF GROUP BERHAD BERHAD 2.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Nov 2023

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Nov 2023	30 Nov 2022	30 Nov 2023	30 Nov 2022
		$$'000	$$'000	$$'000	$$'000

1	Revenue	38,542	0	80,138	0
2	Profit/(loss) before tax	16,640	0	34,584	0
3	Profit/(loss) for the period	12,459	0	25,981	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	12,214	0	25,336	0
5	Basic earnings/(loss) per share (Subunit)	0.27	0.00	0.56	0.00
6	Proposed/Declared dividend per share (Subunit)	0.21	0.00	0.21	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0200		0.0100

icy97

ALPHA IVF GROUP BERHAD

Date of Listing	22 Mar 2024
Enlarged Issued Share Capital in the following
Units	4,860,000,000
Currency	Malaysian Ringgit (MYR)
Par Value($$) (if applicable)
Enlarged Issued Share Capital ($$)	119,725,963.000
Stock Code	0303
Stock Name	ALPHA
ISIN code	MYQ0303OO006
Board	ACE Market
Bursa Sector	HEALTH CARE
Bursa Sub Sector	HEALTH CARE PROVIDERS
Do you wish to list any child stock / new type of securities in conjunction with the IPO/Admission to LEAP Market?	No

icy97

ALPHA IVF GROUP BERHAD

Particulars of substantial Securities Holder

Name	DR NG PENG WAH
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	22 Mar 2024	130,057,564	Others	Direct Interest
	Name of registered holder	DR NG PENG WAH
	Description of "Others" Type of Transaction	Offer for sale

Circumstances by reason of which change has occurred	Offer for sale in conjunction with the Initial Public Offering
Nature of interest	Direct Interest
Direct (units)	404,278,989
Direct (%)	8.318
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	404,278,989
Date of notice	22 Mar 2024
Date notice received by Listed Issuer	22 Mar 2024

Name	DATO DR LEE SOON SOO
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	22 Mar 2024	531,793,047	Others	Direct Interest
	Name of registered holder	DATO DR LEE SOON SOO
	Description of "Others" Type of Transaction	Offer for sale
2	22 Mar 2024	143,114,029	Others	Indirect Interest
	Name of registered holder	ACE SPECIALISTS SDN BHD
	Description of "Others" Type of Transaction	Offer for sale

Circumstances by reason of which change has occurred	Offer for sale in conjunction with the Initial Public Offering
Nature of interest	Direct and Indirect Interest
Direct (units)	1,653,058,442
Direct (%)	34.013
Indirect/deemed interest (units)	446,864,512
Indirect/deemed interest (%)	9.195
Total no of securities after change	2,099,922,954
Date of notice	22 Mar 2024
Date notice received by Listed Issuer	22 Mar 2024

Name	ACE SPECIALISTS SDN BHD
Address	F-3-10 Boulevard Business Park Off Jalan Kuching Kuala Lumpur 51200 Wilayah Persekutuan Malaysia.
Company No.	201701044571 (1258744-X)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	22 Mar 2024	143,114,029	Others	Direct Interest
	Name of registered holder	ACE SPECIALISTS SDN BHD
	Address of registered holder	F-3-10 BOULEVARD BUSINESS PARK OFF JALAN KUCHING 51200 KUALA LUMPUR WILAYAH PERSEKUTUAN
	Description of "Others" Type of Transaction	Offer for sale

Circumstances by reason of which change has occurred	Offer for sale in conjunction with the Initial Public Offering
Nature of interest	Direct Interest
Direct (units)	444,864,512
Direct (%)	9.153
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	444,864,512
Date of notice	22 Mar 2024
Date notice received by Listed Issuer	22 Mar 2024

Name	MADAM LEE SOON AI
Nationality/Country of incorporation	Singapore
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	22 Mar 2024	139,364,233	Others	Direct Interest
	Name of registered holder	LEE SOON AI
	Description of "Others" Type of Transaction	Offer for sale

Circumstances by reason of which change has occurred	Offer for sale in conjunction with the Initial Public Offering
Nature of interest	Direct Interest
Direct (units)	433,208,415
Direct (%)	8.914
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	433,208,415
Date of notice	22 Mar 2024
Date notice received by Listed Issuer	22 Mar 2024

Name	DR LEONG WAI YEW
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	22 Mar 2024	102,832,796	Others	Direct Interest
	Name of registered holder	DR LEONG WAI YEW
	Description of "Others" Type of Transaction	Offer for sale

Circumstances by reason of which change has occurred	Offer for sale in conjunction with the Initial Public Offering
Nature of interest	Direct Interest
Direct (units)	319,651,833
Direct (%)	6.577
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	319,651,833
Date of notice	22 Mar 2024
Date notice received by Listed Issuer	22 Mar 2024

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 29 Feb 2024

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		29 Feb 2024	28 Feb 2023	29 Feb 2024	28 Feb 2023
		$$'000	$$'000	$$'000	$$'000

1	Revenue	40,703	0	120,841	0
2	Profit/(loss) before tax	18,012	0	52,596	0
3	Profit/(loss) for the period	13,772	0	39,753	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	13,588	0	38,924	0
5	Basic earnings/(loss) per share (Subunit)	0.30	0.00	0.87	0.00
6	Proposed/Declared dividend per share (Subunit)	0.49	0.00	0.70	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0100		0.0100

icy97

ALPHA IVF GROUP BERHAD

Date of change	10 Aug 2024
Name	MR SIDDHARTA MISHRA
Age	48
Gender	Male
Nationality	India
Type of change	Resignation
Designation	Chief Operating Officer
Reason	Personal reasons.

icy97

ALPHA IVF GROUP BERHAD

Date of change	12 Aug 2024
Name	MR TAN KAY PAU
Age	35
Gender	Male
Nationality	Malaysia
Type of change	Appointment
Designation	Others

Qualifications

No Qualifications Major/Field of Study Institute/University Additional Information 1 Masters Masters in Business Administration (MBA) Inti International University, Malaysia 2 Masters Master of Arts (MA) in Management Studies University of Hertfordshire, United Kingdom 3 Degree Bachelor of Arts (BA) in International Business Administration University of Hertfordshire, United Kingdom 4 Degree Bachelor of International Business Inti International University, Malaysia
Working experience and occupation	(1)  2023-2024 - Malaysia Healthcare Travel Council (Vice President, Business Sustainability)(2)  2021-2023 - UCSI Hospital Sdn Bhd (Director, Business Development)(3)  2017-2021 - ALPS Global Holding Berhad (Senior Vice President, Group Investments & Operations)(4)  2016-2017 - IMU Healthcare Sdn Bhd (Executive, Oral Health Centre)(5)  2015-2016 - Raffles Medical Group (Cluster Manager, Operations)(6)  2011-2014 - Mahkota Medical Centre Sdn Bhd (Executive, Management)
Directorships in public companies and listed issuers (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Nil

Remarks :

Designation in Alpha IVF Group Berhad - Acting Group Chief Operating Officer

icy97

Type	Announcement
Subject	OTHERS
Description	ALPHA IVF GROUP BERHAD ("ALPHA IVF" OR "THE COMPANY") - SHAREHOLDERS' AGREEMENT BETWEEN ALPHA IVF SYSTEMS SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY), DATO' DR. LEE SOON SOO, DR. NG PENG WAH, DR. ROMERICO F. TORRES AND DR. MARIA VICTORIA TAN
On behalf of the Company, the Board wishes to announce that Alpha IVF Systems Sdn. Bhd., a wholly-owned subsidiary of the Company, has on 3 September 2024 entered into a Shareholders' Agreement with Dato' Dr. Lee Soon Soo, Dr. Ng Peng Wah, Dr. Romerico F. Torres and Dr. Maria Victoria Tan to regulate the relationship as the initial incorporators/shareholders to form Alpha IVF (Manila) Incorporated, a corporation to be registered under the Philippines laws. Please refer to the attached document for further details. This announcement is dated 3 September 2024.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3480929

Attachments AIG - Annt (SHA - Manila) (final).pdf